Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Rabies Diagnostics Market Set To Climb From $1.89 Billion In 2026 To $2.45 Billion By 2030
The rabies diagnostics market has witnessed substantial expansion over recent years. It is projected to increase from $1.78 billion in 2025 to $1.89 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.6%. This historical growth was primarily driven by factors such as the high prevalence of rabies in animals, growing awareness of rabies prevention, the expansion of veterinary diagnostic laboratories, government initiatives aimed at rabies control, and advancements in diagnostic reagents and kits.
The rabies diagnostics market is projected to experience substantial expansion over the coming years. This market is forecast to reach $2.45 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this growth during the projection period include the integration of AI-powered diagnostic instruments, an increasing need for rapid point-of-care tests, the broadening of mobile-based disease surveillance systems, advancements in molecular and serology techniques, and growing public-private partnerships aimed at rabies elimination. Key trends anticipated during this forecast timeframe encompass quick point-of-care rabies testing, sophisticated molecular diagnostic methodologies, the incorporation of AI into rabies detection, mobile-enabled rabies surveillance platforms, and highly sensitive serology testing.
Get A Free Sample Report With In-Depth Market Insights:
Rabies Diagnostics Market Growth Factors: What’s Supporting Expansion?
The growing occurrence of rabies is projected to fuel expansion in the rabies diagnostics market. Rabies, a preventable viral disease, typically spreads through the bite of an infected animal. This virus targets the central nervous systems of mammals, ultimately resulting in brain damage and fatalities. Diagnosing rabies involves identifying the virus in both humans and animals through various diagnostic tests and methods. Furthermore, an increase in animal-transmitted infectious diseases has positively influenced the need for rabies diagnostics. For example, data from the South Dakota Department of Health (SD DOH), a US government administration, in April 2024 showed that 20 animals in South Dakota tested positive for rabies in 2023. This marked a 122% increase from the 9 cases recorded in 2022. Among these rabid animals, one was a domestic animal (a cow), while the other 19 were wild animals, specifically 18 bats and 1 skunk. Consequently, the rising prevalence of rabies is set to be a key driver for the rabies diagnostics market.
Rabies Diagnostics Market Segment Analysis Spotlighting Growth Areas
The rabies diagnostics market covered in this report is segmented –
1) By Diagnostic Method: Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests
2) By Technology: ELISA Or Immunohistochemistry, Chromatography Techniques, PCR, Other Technologies
3) By End-User: Hospital, Diagnostic Centers, Cancer Palliative Care Clinics, Other End-Users
Subsegments:
1) By Fluorescent Antibody Test: Direct Fluorescent Antibody Test (DFA)
2) By Immunohistochemical: Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting
3) By Amplification Methods: Polymerase Chain Reaction (PCR), Reverse Transcription PCR (RT-PCR)
4) By Histologic Examination: Microscopic Examination, Tissue Staining Techniques
5) By Serology Tests: Virus Neutralization Test (VNT), Enzyme-Linked Immunosorbent Assay (ELISA)
Rabies Diagnostics Market Industry Trends: What’s Reshaping Demand?
Major companies in the rabies diagnostic market are developing innovative products, such as rabies antibody test kits, to sustain their position. A rabies antibody test kit is a diagnostic tool used to detect antibodies in the blood, assessing immunity or the need for additional rabies vaccination. For instance, in February 2024, BioStone Animal Health, a US-based diagnostic company, launched AsurDx. This rabies antibody test kit identifies antibodies specific to the rabies virus in mammalian serum samples using a rapid and sensitive ELISA method. It provides a cost-effective solution for assessing rabies immunity, suitable for both vaccinated animals and those at risk. The kit is designed for simple use and delivers reliable results, helping ensure animals meet the standard of 0.5 international units (UL) per ml for immune activity against rabies.
Rabies Diagnostics Market Leading Players And Competitive Positioning
Major companies operating in the rabies diagnostics market are Bio-Rad Laboratories Inc., The Merck Group, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc., InBios International Inc., KHB Shanghai Kehua Bio-Engineering Co. Ltd., Meridian Bioscience Inc., MP Biomedicals LLC, Neogen Corporation, Randox Laboratories Ltd., SDIX LLC, Sigma-Aldrich Corporation
View The Full Rabies Diagnostics Market Report:
Rabies Diagnostics Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the rabies diagnostics market in 2025. The regions covered in the rabies diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
